Nuvation Bio (NUVB) shares climbed by more than 43% in recent trading on Wednesday after B. Riley initiated coverage of the biopharmaceutical firm with a buy rating and a price target of $12.
Trading volume topped 27.5 million shares against a daily average of around 7.6 million.
Nuvation Bio shares were recently 43.1% higher at $6.87.
Price: 6.92, Change: +2.12, Percent Change: +44.06
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.